Home » Stocks » INTI

Inhibitor Therapeutics, Inc. (INTI)

Stock Price: $0.0401 USD -0.0080 (-16.46%)
Updated Jan 19, 2021 3:05 PM EST - Market closed
Market Cap 16.44M
Revenue (ttm) n/a
Net Income (ttm) -1.84M
Shares Out 373.15M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $0.0401
Previous Close $0.0480
Change ($) -0.0080
Change (%) -16.46%
Day's Open 0.0401
Day's Range 0.0401 - 0.0401
Day's Volume 2,000
52-Week Range 0.03 - 0.138

News

There are no news available yet.

About INTI

Inhibitor Therapeutics operates as a pharmaceutical development company that discovers, develops, and plans to commercialize therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders in the United States. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including cell differentiation, tissue polarity, and cell proliferation. It focuses on developing its lead product, SUBA-Itraconazole, a patented oral formulation for prostate and lung cancer. The company w... [Read more...]

Industry
Biotechnology
Founded
1992
CEO
Nicholas Virca
Employees
2
Stock Exchange
OTCMKTS
Ticker Symbol
INTI
Full Company Profile

Financial Performance

Financial Statements